Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Haemonetics Corporation - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
HAE
New York
3850
www.haemonetics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Haemonetics Corporation
3 Value Stocks with Open Questions
- Jan 20th, 2026 9:31 pm
Is Haemonetics (HAE) Offering An Opportunity After Recent Share Price Weakness
- Jan 16th, 2026 1:12 am
Is it Apt to Retain HAE Stock in Your Portfolio for Now?
- Jan 15th, 2026 7:42 am
1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges
- Jan 14th, 2026 9:31 pm
Haemonetics price target raised to $93 from $90 at Barrington
- Jan 13th, 2026 5:44 am
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
- Jan 12th, 2026 7:00 am
Haemonetics acquires Ireland-based Vivasure
- Jan 12th, 2026 4:53 am
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
- Jan 11th, 2026 11:48 pm
How Recent Moves Are Rewriting The Haemonetics (HAE) Story On Guidance And Valuation
- Jan 11th, 2026 6:04 pm
A Look At Haemonetics (HAE) Valuation After Recent Share Price Momentum
- Jan 10th, 2026 11:08 pm
Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report?
- Jan 9th, 2026 10:10 am
Haemonetics to acquire Vivasure Medical
- Jan 9th, 2026 7:41 am
Vivasure Medical Announces Acquisition by Haemonetics Corporation
- Jan 9th, 2026 6:00 am
Haemonetics Acquires Vivasure Medical Limited
- Jan 9th, 2026 4:15 am
1 Small-Cap Stock Worth Your Attention and 2 We Avoid
- Jan 8th, 2026 9:33 pm
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
- Jan 7th, 2026 4:17 pm
Investors in Haemonetics (NYSE:HAE) have unfortunately lost 35% over the last five years
- Jan 6th, 2026 5:36 am
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2026 4:00 am
3 Low-Volatility Stocks We Think Twice About
- Jan 1st, 2026 9:33 pm
Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)?
- Dec 25th, 2025 5:42 am
Scroll